Wegovy has become one of the most talked-about medications in the country, but getting insurance to cover it is another story entirely. If your pharmacy benefits are managed by CVS Caremark, you are probably asking: does CVS Caremark cover Wegovy? The answer is not a simple yes or no. It depends on your specific plan, your medical history, and whether your employer or insurer chose to include weight-management drugs in the formulary.
Free Market Healthcare is an independent education site and is not affiliated with, endorsed by, or sponsored by CVS Caremark or Novo Nordisk. This article is general information, not medical or insurance advice.
First, Understand That CVS Caremark Is a PBM — Not Your Insurer
CVS Caremark is a pharmacy benefit manager (PBM). It administers the prescription-drug portion of a health plan on behalf of the employer or insurer that hired it — negotiating with drug manufacturers, building formularies (covered-drug lists), and processing pharmacy claims. It does not, by itself, decide that “Wegovy is covered” for everyone. Your actual insurer or self-funded employer decides which benefits to buy, including whether weight-loss drugs are covered at all. That is why two people who both “have CVS Caremark” can get completely different answers about the same drug. For a broader look at how PBMs make formulary decisions, our CVS Caremark PBM guide explains the process.
What Is Wegovy and Why Is It So Expensive?
Wegovy (semaglutide 2.4 mg) is an injectable medication approved by the FDA in June 2021 for chronic weight management in adults with obesity (BMI of 30 or greater) or overweight (BMI of 27 or greater) with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol. In 2024 the FDA also approved Wegovy to reduce the risk of major cardiovascular events in certain adults with established cardiovascular disease. Manufactured by Novo Nordisk, Wegovy works by mimicking the GLP-1 hormone, which regulates appetite and food intake.
The list price for Wegovy runs roughly $1,300 to $1,400 per month without insurance. That price point makes coverage questions critical for most patients. According to KFF, anti-obesity medications represent a growing challenge for health plans trying to balance clinical benefit against budget impact, since widespread coverage could cost billions annually — one reason many plans exclude weight-loss drugs outright.
CVS Caremark’s General Position on Weight-Loss Drugs
CVS Caremark does not make a blanket coverage decision that applies to all plans. Instead, each employer or insurer that contracts with CVS Caremark decides whether to include weight-loss medications in their formulary. Some plans cover Wegovy with restrictions. Others exclude it entirely. A smaller number cover it without significant barriers.
On its 2025 standard commercial “template” formulary, CVS Caremark named Wegovy the preferred GLP-1 for weight management and removed the competing drug Zepbound (tirzepatide), a change that took effect July 1, 2025. This affected the standard template that many plans adopt — but not all. Employers and insurers can and do customize their formularies, and annual updates (typically effective January 1) can change a drug’s status from year to year. In short: the template preferring Wegovy is a useful signal, but it is not a guarantee for your plan. Treat this as background to verify, because formularies change and many plans deviate from the template. Your plan’s specific formulary is always the definitive source.
Checking Your Specific Coverage
Three steps determine whether your plan covers Wegovy.
First, log in to Caremark.com and use the formulary/drug-list search tool. Enter “Wegovy” or “semaglutide” and see if it appears in your plan’s drug list. If it shows up, note the tier and any restrictions such as prior authorization or step therapy.
Second, call the member services number printed on your CVS Caremark ID card and ask a representative to verify coverage. (Use the number on your own card; do not rely on any number you find elsewhere.) Provide the medication name, dose, and NDC number if you have it. The representative can tell you the expected cost share and any requirements you must meet before the drug will be approved.
Third, ask your prescriber’s office to submit a test claim or benefits investigation. Many prescribers’ offices have staff who specialize in navigating insurance coverage and can determine your benefits before writing the prescription. Because Wegovy is prescriber-directed, this coordination with your doctor is essential.
Prior Authorization Requirements
Even when Wegovy is on the formulary, prior authorization is almost always required. CVS Caremark’s prior authorization criteria for Wegovy typically include documentation of BMI at or above the FDA-approved threshold, evidence of previous weight-management efforts (such as diet and exercise programs), and sometimes proof that the patient has tried and failed other weight-loss approaches or medications (step therapy).
Your prescribing doctor submits the prior authorization request, along with supporting medical records. CVS Caremark reviews the request against the plan’s clinical criteria and issues a decision, generally within a few days for standard requests and faster for urgent ones. Denials can be appealed, and the appeal process involves additional clinical documentation.
Prior authorization for anti-obesity medications is denied at relatively high rates compared with many other drug classes, making thorough documentation by your physician essential. If your request is denied, ask exactly which criterion was not met so your prescriber can address it on appeal.
What If Your Plan Does Not Cover Wegovy?
If Wegovy is excluded from your formulary, you have several options. Your doctor can submit a formulary-exception request, arguing medical necessity based on your specific health conditions. CVS Caremark evaluates these requests individually, and some are approved, particularly when the patient has obesity-related complications that other treatments have not adequately addressed.
Therapeutic alternatives may also be covered. Saxenda (liraglutide), another GLP-1 receptor agonist approved for weight management, appears on some formularies. Coverage of Zepbound varies by plan. If you have type 2 diabetes, a diabetes-indicated GLP-1 such as Ozempic (semaglutide at diabetes doses) may be covered under the diabetes category rather than weight management — though using it off-label for weight loss alone would not qualify. Your prescriber should guide any change in therapy.
Novo Nordisk also offers direct pricing and savings for Wegovy that do not depend on your PBM. Per the manufacturer’s official Wegovy site, commercially insured, eligible patients may pay “as little as $25 per month” with the Wegovy Savings Offer, and a cash NovoCare pharmacy price has been offered in the low-to-mid hundreds per month (recently around $349/month for the pen after an introductory period). These terms change frequently and eligibility rules apply, so verify the current offer directly with Novo Nordisk. Cash-pay discount tools like GoodRx exist but remain expensive given Wegovy’s high list price.
Medicare and Wegovy Coverage
Medicare Part D historically has not covered medications prescribed solely for weight loss, based on a statutory exclusion in the Social Security Act. However, the FDA’s 2024 approval of Wegovy for cardiovascular risk reduction changed the equation. Medicare Part D plans may now cover Wegovy when it is prescribed for cardiovascular risk reduction in patients with established cardiovascular disease, rather than for weight loss alone.
This distinction matters. If your doctor prescribes Wegovy specifically for cardiovascular benefit and documents the clinical rationale, your Medicare Part D plan administered by CVS Caremark may cover it. Coverage for weight loss alone remains excluded under most Medicare plans. Separately, Novo Nordisk has offered a GLP-1 “bridge” program under which some eligible Medicare beneficiaries pay $50 per month for a limited time (recently stated through December 31, 2027) — verify current eligibility and terms with the manufacturer. For more on Medicare prescription options, see our guide to the best mail order pharmacy for Medicare and our article on whether Medicare covers Wegovy.
Cost Expectations When Covered
Even with coverage, Wegovy is rarely cheap. Specialty-tier placement typically means coinsurance (often a percentage of the drug’s cost) rather than a flat copay, so your monthly share can run into the hundreds of dollars until you reach your out-of-pocket maximum.
Some plans place Wegovy on a lower tier with a flat copay, which is much more predictable. The variation between plans is enormous, which is why checking your specific formulary and cost estimate — and combining it with any manufacturer savings you qualify for — is essential before starting therapy.
Frequently Asked Questions
Does CVS Caremark cover Wegovy for weight loss?
It depends entirely on your specific plan. CVS Caremark is a PBM, and your employer or insurer decides whether weight-loss drugs are a covered benefit. Some plans include Wegovy with prior authorization; others exclude it. Log in to Caremark.com or call the number on your member ID card to check your plan.
How much does Wegovy cost with CVS Caremark insurance?
If covered, your cost depends on the formulary tier — specialty-tier coinsurance can mean hundreds of dollars a month, while some plans offer a lower flat copay. Check your plan’s cost estimator for a personalized quote, and see whether a Novo Nordisk savings offer can reduce your share.
Can my doctor appeal a Wegovy denial from CVS Caremark?
Yes. Your doctor can submit a formal appeal with additional clinical documentation supporting medical necessity. Appeals have a defined timeline, and you generally have the right to an external review if the internal appeal is denied.
Did CVS Caremark drop Zepbound in favor of Wegovy?
On its 2025 standard commercial template formulary, CVS Caremark made Wegovy the preferred GLP-1 for weight management and removed Zepbound effective July 1, 2025. However, many plans customize their formularies and this can change over time, so confirm what your specific plan covers.
Will CVS Caremark cover Wegovy under Medicare?
Medicare Part D may cover Wegovy when prescribed for cardiovascular risk reduction, not solely for weight loss. Check with your specific Medicare Part D plan administered by CVS Caremark for current coverage status and requirements.
Your Next Steps
Answering “does CVS Caremark cover Wegovy” requires checking your specific plan, not relying on general information — because CVS Caremark is the benefit administrator, while your employer or insurer sets the actual coverage. Start with the online formulary tool at Caremark.com, confirm with a call to the number on your member ID card, and work with your prescriber to submit prior authorization with thorough documentation. If denied, explore the appeals process, therapeutic alternatives, and Novo Nordisk savings programs. Weight management is a medical issue, and the coverage landscape is evolving as more evidence supports the clinical value of GLP-1 medications. Stay informed about your plan’s annual formulary changes, especially during open enrollment. For more on how your pharmacy benefits work, visit our healthcare policy guide.
TL;DR: CVS Caremark is a PBM, not your insurer, so whether it covers Wegovy comes down to your specific plan’s formulary and whether weight-loss drugs are a covered benefit. Many plans exclude them; those that cover Wegovy usually require prior authorization. On the 2025 standard commercial template, Wegovy became the preferred GLP-1 (Zepbound removed July 1, 2025), but plans customize — verify your own via Caremark.com and the number on your ID card. Novo Nordisk offers separate savings and cash pricing (terms change).
This article is for general information only and is not medical, insurance, or financial advice. Coverage rules and prices change frequently; confirm details with your plan, your prescriber, and the manufacturer. Free Market Healthcare is not affiliated with CVS Caremark or Novo Nordisk.